CAM
ORGO icon

Cresset Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Cresset Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,964
Closed -$44.8K – 1961
2023
Q4 		$44.8K Hold
10,964
– – ﹤0.01% 1788
2023
Q3 		$34.9K Sell
10,964
-63
-0.6% -$200 ﹤0.01% 1759
2023
Q2 		$36.6K Buy
+11,027
New +$32.6K ﹤0.01% 1859

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Cresset Asset Management's ORGO Position: Q1 2024 in Review

Cresset Asset Management sold out of Organogenesis Holdings (ORGO) in Q1 2024, closing a stake of 10,964 shares — an estimated $44.8K sold.

Cresset Asset Management first reported a position in ORGO in Q2 2023 and held it in 3 quarters. The position peaked at $44.8K in Q4 2023. 124 funds tracked by Wall St. Rank hold ORGO as of Q1 2024.

  • Cresset Asset Management reported no remaining Organogenesis Holdings position as of Q1 2024 after selling out during the quarter.
  • Cresset Asset Management sold 10,964 Organogenesis Holdings shares in Q1 2024, an estimated $44.8K.
  • Cresset Asset Management first reported a position in Organogenesis Holdings in Q2 2023 and held it in 3 quarters.
  • Cresset Asset Management's Organogenesis Holdings position peaked at $44.8K in Q4 2023.
  • 124 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2024.

Based on Cresset Asset Management's 13F filing for Q1 2024, filed 15 May 2024.